Michel Burnier

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


907 publications

... | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | ...
2017
 
Comment initier un traitementantihypertenseur ? De l’évidenceà la personnalisation [How to start an antihypertensive treatment: from evidence to personalized choice]
Forni Ogna V., Braconnier P., Wuerzner A., Burnier M., Wuerzner G., 2017/09/13. Revue medicale suisse, 13 (574) pp. 1558-1564. Peer-reviewed.
[Pmid][serval:BIB_5560E941B629]
 
Femmes médecins, anges gardiens ? []
Pechère-Bertschi A., Wuerzner G., Burnier M., 2017/09/13. Revue medicale suisse, 13 (574) pp. 1555-1556. Peer-reviewed.
[Pmid][serval:BIB_D444799A92D8]
 
Hypertension et dysplasie fibromusculaire :au-delà des artères rénales [Fibromuscular dysplasia and hypertension : beyond renal arteries]
Wuerzner G., Krieger C., Bouchardy J., Toubiana L., Delmotte P., Van der Niepen P., Déglise S., Qanadli S., Burnier M., Mazzolai L. et al., 2017/09/13. Revue medicale suisse, 13 (574) pp. 1580-1583. Peer-reviewed.
[Pmid][serval:BIB_7D763B42C3AD]
Safety and Tolerability Study of an Intravenously Administered Small Interfering Ribonucleic Acid (siRNA) Post On-Pump Cardiothoracic Surgery in Patients at Risk of Acute Kidney Injury.
Demirjian S., Ailawadi G., Polinsky M., Bitran D., Silberman S., Shernan S.K., Burnier M., Hamilton M., Squiers E., Erlich S. et al., 2017/09. Kidney international reports, 2 (5) pp. 836-843. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6ECEC80232BA]
 
Seasonality of sodium and potassium consumption in Switzerland. Data from three cross-sectional, population-based studies.
Marti-Soler H., Pommier C., Bochud M., Guessous I., Ponte B., Pruijm M., Ackermann D., Forni Ogna V., Paccaud F., Burnier M. et al., 2017/09. Nutrition, metabolism, and cardiovascular diseases, 27 (9) pp. 792-798. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4508E6FF9407]
 
Expertise: no longer a sine qua non for guideline authors?
Messerli F.H., Hofstetter L., Agabiti-Rosei E., Burnier M., Elliott W.J., Franklin S.S., Grodzicki T., Kario K., Kjeldsen S.E., Kostis J.B. et al., 2017/08. Journal of hypertension, 35 (8) pp. 1564-1566. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0677218966CD]
 
Prevention of heart failure mortality and hospitalizations in SPRINT, EMPA-REG, ALLHAT and HYVET: are diuretics the clue?
Burnier M., Narkiewicz K., Kjeldsen S.E., 2017/08. Blood pressure, 26 (4) pp. 193-194. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EC8EC1A7FB57]
 
L’importance de la diminution de la pression artérielle nocturne
Braconnier Philippe, Forni Ogna Valentina, Wuerzner Grégoire, Burnier Michel, 2017/07/19. Info@herz+gefäss, 4 (7) pp. 24-27.
[serval:BIB_21AB1E328798]
Changing trends in end-stage renal disease patients with diabetes.
Lu Y., Stamm C., Nobre D., Pruijm M., Teta D., Cherpillod A., Halabi G., Phan O., Fumeaux Z., Bullani R. et al., 2017/07/11. Swiss medical weekly, 147 pp. w14458. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_03D3BBAF84B1]
Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
Corcillo A., Pivin E., Lalubin F., Pitteloud N., Burnier M., Zanchi A., 2017/07/11. Swiss medical weekly, 147 pp. w14459. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DBE1BC845497]
 
The INTERSTROKE Study: hypertension is by far the most important modifiable risk factor for stroke.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2017/06. Blood pressure, 26 (3) pp. 131-132. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A7BC70C348EB]
 
Hypertension in dialysis patients : a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*
Sarafidis Pantelis A., Persu Alexandre, Agarwal Rajiv, Burnier Michel, de Leeuw Peter, Ferro Charles, Halimi Jean-Michel, Heine Gunnar, Jadoul Michel, Jarraya Faical et al., 2017/04. Journal of Hypertension, 35 (4) pp. 657-676. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5CEC42C65CC0]
 
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH).
Sarafidis P.A., Persu A., Agarwal R., Burnier M., de Leeuw P., Ferro C.J., Halimi J.M., Heine G.H., Jadoul M., Jarraya F. et al., 2017/04/01. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 32 (4) pp. 620-640. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_323A4D0E5076]
 
Is there a place for a dual angiotensin receptor-neprilysin inhibitor in the treatment of hypertension?
Burnier M., 2017/04. Journal of hypertension, 35 (4) pp. 726-728. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E8EFD68A730F]
 
Performance of targeted screening for the identification of hypertension in children.
Bloetzer C., Bovet P., Paccaud F., Burnier M., Chiolero A., 2017/04. Blood pressure, 26 (2) pp. 87-93. Peer-reviewed.
[DOI][Pmid][serval:BIB_7F4F734CF0FF]
 
The INTERSALT Study and the complex relationship between salt intake and blood pressure.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2017/04. Blood pressure, 26 (2) pp. 65-66. Peer-reviewed.
[DOI][Pmid][serval:BIB_0FD7D8288A8D]
Associations of sodium, potassium and protein intake with blood pressure and hypertension in Switzerland.
Glatz N., Chappuis A., Conen D., Erne P., Péchère-Bertschi A., Guessous I., Forni V., Gabutti L., Muggli F., Gallino A. et al., 2017/03/21. Swiss medical weekly, 147 pp. w14411.
[URN][DOI][WoS][Pmid][serval:BIB_74CBC32360B7]
Erratum to: A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges.
Kissling S., Legallais C., Pruijm M., Teta D., Vogt B., Burnier M., Rondeau E., Ridel C., 2017/03/09. BMC nephrology, 18 (1) p. 84. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FF08998BE9AB]
A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges.
Kissling S., Legallais C., Pruijm M., Teta D., Vogt B., Burnier M., Rondeau E., Ridel C., 2017/03/01. BMC nephrology, 18 (1) p. 81. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_10C455BA2F8D]
 
Avancées thérapeutiques dans les maladies rénales associéesaux gammapathies monoclonales [Therapeutic advances in monoclonal gammopathy-associated renal diseases]
Boesch A., Burnier M., Cairoli A., Kissling S., 2017/02/22. Revue medicale suisse, 13 (551) pp. 462-467. Peer-reviewed.
[Pmid][serval:BIB_8EE96736AB0E]
 
Dialyse à domicile : retour vers le futur
Burnier M., Martin P.Y., 2017/02/22. Revue medicale suisse, 13 (551) pp. 443-444. Peer-reviewed.
[Pmid][serval:BIB_493912C7FD6F]
 
Inégalité homme-femme face aux maladies rénales chroniques : mythe ou réalité ? [Gender differences in chronic kidney diseases : myth or reality ?]
Mehier P., Burnier M., Pruijm M., 2017/02/22. Revue medicale suisse, 13 (551) pp. 473-476. Peer-reviewed.
[Pmid][serval:BIB_02558D9BCB15]
 
The Global Burden of Disease Study 2015 and Blood Pressure.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2017/02. Blood pressure, 26 (1) p. 1. Peer-reviewed.
[DOI][Pmid][serval:BIB_8CA335BD1DD1]
Team-based care for improving hypertension management among outpatients (TBC-HTA): study protocol for a pragmatic randomized controlled trial.
Santschi V., Wuerzner G., Chiolero A., Burnand B., Schaller P., Cloutier L., Paradis G., Burnier M., 2017/01/21. BMC cardiovascular disorders, 17 (1) p. 39. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0F777B356984]
 
Hypertension : quoi de neuf ? [Hypertension]
Burnier M., Wuerzner G., 2017/01/11. Revue medicale suisse, 13 (544-545) pp. 61-65. Peer-reviewed.
[Pmid][serval:BIB_E14599BF21E6]
Current Situation of Medication Adherence in Hypertension.
Vrijens B., Antoniou S., Burnier M., de la Sierra A., Volpe M., 2017. Frontiers in pharmacology, 8 p. 100. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B3388FE9F7D7]
 
Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure.
Dao K., Lu Y., Peer C.J., Figg W.D., Stadelmann R., Burnier M., Buclin T., Kissling S., 2017/01. Cancer chemotherapy and pharmacology, 79 (1) pp. 215-218. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_98ACC5BD24F7]
Relevance of positive cardiovascular outcome trial results in clinical practice: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes (ACROSS T2D).
Schernthaner G., Khunti K., Lotan C., Burnier M., Drexel H., Prázný M., 2017. Therapeutics and clinical risk management, 13 pp. 1569-1576. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D4CBAB5EC0EA]
2016
 
Effect of long-term adherence to clopidogrel on the VASP-PRI after elective coronary stent implantation: a randomized controlled study.
Forni Ogna V., Menetrey I., Muller O., Tousset E., Guihard L., Fontana P., Eeckhout E., Eap C.B., Vrijens B., Burnier M. et al., 2016/12. British Journal of Clinical Pharmacology, 82 (6) pp. 1486-1497. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_75F62C85EC0C]
 
Resistant Hypertension: Is the Number of Drugs a Reliable Marker of Resistance?
Burnier M., 2016/12. Hypertension, 68 (6) pp. 1346-1348. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_27B276FD898B]
 
Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets.
Kjeldsen S.E., Stenehjem A., Os I., Van de Borne P., Burnier M., Narkiewicz K., Redon J., Agabiti Rosei E., Mancia G., 2016/12. Blood pressure, 25 (6) pp. 333-336. Peer-reviewed.
[DOI][Pmid][serval:BIB_878BB4E4C120]
 
Renal tissue oxygenation in children with chronic kidney disease due to vesicoureteral reflux.
Chehade H., Milani B., Ansaloni A., Anex C., Bassi I., Piskunowicz M., Stuber M., Cachat F., Burnier M., Pruijm M., 2016/11. Pediatric nephrology, 31 (11) pp. 2103-2111. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0D1D341F3F22]
The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals.
Ehret G.B., Ferreira T., Chasman D.I., Jackson A.U., Schmidt E.M., Johnson T., Thorleifsson G., Luan J., Donnelly L.A., Kanoni S. et al., 2016/10. Nature genetics, 48 (10) pp. 1171-1184. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C3107C8B0FD2]
 
La pollution a-t-elle un impact sur la pression artérielle ? [Does pollution have an impact on blood pressure ?]
Megdiche F., Pivin E., Wuerzner G., Burnier M., 2016/09/14. Revue medicale suisse, 12 (530) pp. 1507-1512. Peer-reviewed.
[Pmid][serval:BIB_876E93557E4F]
 
La recherche d’une hypertension nocturne est-elle utile ? [Usefulness of night-time blood pressure measurement]
Pivin E., Megdiche F., Burnier M., Wuerzner G., 2016/09/14. Revue medicale suisse, 12 (530) pp. 1513-1517. Peer-reviewed.
[Pmid][serval:BIB_C64C6D09E5EA]
 
Médecine personnalisée et hypertension artérielle : effet de mode ou vrai défi ? []
Burnier M., Pechère-Bertschi A., Wuerzner G., 2016/09/14. Revue medicale suisse, 12 (530) pp. 1499-1500. Peer-reviewed.
[Pmid][serval:BIB_16ED259A6F56]
 
Potassium et pression artérielle, une vieille histoire revisitée [Potassium and blood pressure, an old story, revisited]
Zisimopoulou S., Pechère-Bertschi A., Burnier M., 2016/09/14. Revue medicale suisse, 12 (530) pp. 1502-1506. Peer-reviewed.
[Pmid][serval:BIB_E0E487E61AED]
 
Pression artérielle et glaucome : attention à la pression artérielle nocturne [Arterial hypertension and glaucoma: watch out for nocturnal blood pressure]
Martin-Du Pan R., Pruijm M., Burnier M., Sunaric-Megevand G., 2016/09/14. Revue medicale suisse, 12 (530) pp. 1518-1521. Peer-reviewed.
[Pmid][serval:BIB_D7C64BBF0C51]
 
[OP.2A.02] Uromodulin Modulates The Effect Of Salt On Blood Pressure In The General Population.
Ponte B., Pruijm M., Guessous I., Ackermann D., Ehret G., Mohaupt M., Paccaud F., Vogt B., Martin P.Y., Pechere-Berstschi A. et al., 2016/09., 26th Meeting of the European Society of Hypertension (ESH), Paris, June 10-13, 2016 pp. e15 dans Journal of Hypertension. Peer-reviewed, Ovid Technologies (Wolters Kluwer Health).
[DOI][WoS][serval:BIB_E8B482DF3CF6]
 
[OP.7D.07] INFLUENCE OF RENAL SYMPATHETIC DENERVATION ON BLOOD PRESSURE VARIABILITY: EXPERIENCE AT 11 EUROPEAN EXPERT CENTERS.
Persu A., Gordin D., Jacobs L., Thijs L., Bots M.L., Miroslawska A., Spaak J., Rosa J., De Jong M., Berra E. et al., 2016/06/01. Journal of Hypertension, 34 Suppl 2 - ESH 2016 Abstract Book pp. e96. Peer-reviewed.
[DOI][Pmid][serval:BIB_661CDE95BB4D]
Sociodemographic, behavioral and genetic determinants of allostatic load in a Swiss population-based study.
Petrovic D., Pivin E., Ponte B., Dhayat N., Pruijm M., Ehret G., Ackermann D., Guessous I., Younes S.E., Pechère-Bertschi A. et al., 2016/05. Psychoneuroendocrinology, 67 pp. 76-85. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_6553DCDBB531]
 
Association between obesity and glomerular hyperfiltration: the confounding effect of smoking and sodium and protein intakes.
Ogna A., Forni Ogna V., Bochud M., Guessous I., Paccaud F., Burnier M., Wuerzner G., 2016/04. European journal of nutrition, 55 (3) pp. 1089-1097. Peer-reviewed.
[DOI][Pmid][serval:BIB_C229DE25A98E]
 
La prise en charge de l'insuffisance rénale doit devenir une priorité humanitaire [Chronic kidney insufficiency management must become a humanitarian priority]
Martin P.Y., Burnier M., 2016/02/24. Revue medicale suisse, 12 (507) pp. 379-380.
[Pmid][serval:BIB_F1C236977BED]
 
Mesures préventives de l'insuffisance rénale aiguë [Preventive measures of acute renal failure]
Schwotzer N., Burnier M., Kissling S., 2016/02/24. Revue medicale suisse, 12 (507) pp. 393-397. Peer-reviewed.
[Pmid][serval:BIB_87E1FFB36B1F]
 
Quand appeler le néphrologue aux urgences? [When should the nephrologist be called in the emergency room?]
Favre N., Burnier M., Kissling S., 2016/02/24. Revue medicale suisse, 12 (507) pp. 398-403. Peer-reviewed.
[DOI][Pmid][serval:BIB_A04C78A58A3D]
 
Hypertension artérielle [News in blood pressure in 2015]
Megdiche F., Pivin E., Wuerzner G., Burnier M., 2016/01/13. Revue medicale suisse, 12 (500) pp. 44-48.
[Pmid][serval:BIB_087E7F1E4051]
 
[OP.8E.08] Regional variations in the associations of dietary patterns with blood pressure and hypertension in Switzerland
Burnier M., Chappuis A., Glatz N., Bochud M., Swiss Salt Survey Group, 2016. pp. e110 dans Journal of Hypertension.
[DOI][Pmid][serval:BIB_C4CA09F0CB6E]
 
Associations of Urinary Uromodulin with Clinical Characteristics and Markers of Tubular Function in the General Population.
Pruijm M., Ponte B., Ackermann D., Paccaud F., Guessous I., Ehret G., Pechère-Bertschi A., Vogt B., Mohaupt M.G., Martin P.Y. et al., 2016. Clinical Journal of the American Society of Nephrology, 11 (1) pp. 70-80. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8D0A952B5546]
 
Blockade of the Renin-Angiotensin System and the Risk of Acute Kidney Injury.
Burnier M., 2016. Journal of Clinical Hypertension, 18 (6) pp. 512-513. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0E9A541DE1DE]
Blood Oxygenation Level-Dependent MRI to Assess Renal Oxygenation in Renal Diseases: Progresses and Challenges.
Pruijm M., Milani B., Burnier M., 2016. Frontiers in physiology, 7 p. 667. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_3DC4FE57FDCF]
Chronic kidney disease in type 2 diabetic patients followed-up by primary care physicians in Switzerland: prevalence and prescription of antidiabetic drugs.
Lamine F., Lalubin F., Pitteloud N., Burnier M., Zanchi A., 2016. Swiss Medical Weekly, 146 pp. w14282. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2C70F77224E2]
 
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.
Zanchetti A., Liu L., Mancia G., Parati G., Grassi G., Stramba-Badiale M., Silani V., Bilo G., Corrao G., Zambon A. et al., 2016. Journal of Hypertension, 34 (3) pp. 393-396. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FDD05C39E3D5]
 
CYP17A1 Enzyme activity is linked to ambulatory blood pressure in a family-based population study.
Ackermann D., Pruijm M., Ponte B., Guessous I., Ehret G., Escher G., Dick B., Al-Alwan H., Vuistiner P., Paccaud F. et al., 2016. American Journal of Hypertension, 29 (4) pp. 484-493. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2FA85CEC0B5C]
 
FGF23 markers of mineral metabolism in subjects with preserved renal function
Dhayat Nasser, Ackermann Daniel, Pruijm Menno, Ponte Belen, Ehret Georg, Guessous Idris, Leichtle Alexander Benedikt, Paccaud Fred, Mohaupt Markus, Fiedler Georg-Martin et al., 2016., 53rd ERA-EDTA Congress, May 21st-24th, 2016, Vienna, Austria p. 1459 dans Nephrology Dialysis Transplantation. Peer-reviewed.
[DOI][WoS][serval:BIB_21B86BCAB510]
 
Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
Dhayat N.A., Ackermann D., Pruijm M., Ponte B., Ehret G., Guessous I., Leichtle A.B., Paccaud F., Mohaupt M., Fiedler G.M. et al., 2016. Kidney International, 90 (3) pp. 648-657. Peer-reviewed.
[DOI][Pmid][serval:BIB_76C2377C0DED]
 
Improving treatment satisfaction to increase adherence.
Chiolero A., Burnier M., Santschi V., 2016. Journal of Human Hypertension, 30 (5) pp. 295-296. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3D3D78933290]
 
Introduction au conseil pharmaceutique / Einführung in die pharmazeutische Beratung
Bugnon Olivier, Berger Jérôme, Burnier Michel, Mesnil Marcel, Benedetti Cristina, Dommer Schwaller Jeannette, 2016. dans pharManuel - Manuel pratique du pharmacien suisse.
[serval:BIB_349288862CB8]
 
Physiologic Control of the Circadian Variability in Blood Pressure
Burnier Michel, Bonny Olivier, Wuerzner Gregoire, 2016. pp. 149-163 dans Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics, Springer.
[DOI][serval:BIB_EB6B8ACD77F2]
Prevalence and determinants of chronic kidney disease in the Swiss population.
Forni Ogna V., Ogna A., Ponte B., Gabutti L., Binet I., Conen D., Erne P., Gallino A., Guessous I., Hayoz D. et al., 2016. Swiss Medical Weekly, 146 pp. w14313. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A950F47888E5]
Relation of 24-hour urinary caffeine and caffeine metabolite excretions with self-reported consumption of coffee and other caffeinated beverages in the general population.
Petrovic D., Estoppey Younes S., Pruijm M., Ponte B., Ackermann D., Ehret G., Ansermot N., Mohaupt M., Paccaud F., Vogt B. et al., 2016. Nutrition & metabolism, 13 p. 81. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F638EC8299DC]
2015
 
A new technique with high reproducibility to estimate renal oxygenation using BOLD-MRI in chronic kidney disease.
Piskunowicz M., Hofmann L., Zuercher E., Bassi I., Milani B., Stuber M., Narkiewicz K., Vogt B., Burnier M., Pruijm M., 2015/12. Magnetic Resonance Imaging, 33 (3) pp. 253-261. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DEC39B5AFEAD]
 
Drug adherence monitoring in clinical trials: a necessity for a correct assessment of the efficacy and safety of antihypertensive therapies.
Burnier M., Wuerzner G., 2015/12. Journal of Hypertension, 33 (12) pp. 2395-2398. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4204270F0B42]
Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system.
Muller M.E., Forni Ogna V., Maillard M., Stoudmann C., Zweiacker C., Anex C., Wuerzner G., Burnier M., Bonny O., 2015/12. Pflugers Archiv, 467 (12) pp. 2413-2421. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A227854F597B]
New anthropometry-based age- and sex-specific reference values for urinary 24-hour creatinine excretion based on the adult Swiss population (epublish)
Forni Ogna V., Ogna A., Vuistiner P., Pruijm M., Ponte B., Ackermann D., Gabutti L., Vakilzadeh N., Mohaupt M., Martin P.Y. et al., 2015/12. Bmc Medicine, 13 (1) p. 40. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6C1E4D18FFDF]
 
Pharmacokinetic modelling of dialytic clearance in a case of acyclovir intoxication.
Kissling S., Fuchs A., Gobin N., Vogt B., Burnier M., Decosterd L.A., Buclin T., Livio F., 2015/11. International Journal of Antimicrobial Agents, 45 (3) pp. 325-327. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_96AB126BAC33]
 
Heritability of ambulatory and office blood pressure in the Swiss population.
Alwan H., Ehret G., Ponte B., Pruijm M., Ackermann D., Guessous I., Staessen J.A., Asayama K., Kutalik Z., Vuistiner P. et al., 2015/10. Journal of Hypertension, 33 (10) pp. 2061-2067. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B07A53DD0B4A]
 
Serum 25-hydroxyvitamin D level and kidney function decline in a Swiss general adult population.
Guessous I., McClellan W., Kleinbaum D., Vaccarino V., Hugues H., Boulat O., Marques-Vidal P., Paccaud F., Theler J.M., Gaspoz J.M. et al., 2015/07/07. Clinical journal of the American Society of Nephrology, 10 (7) pp. 1162-1169. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9E92763539D2]
 
Intermittent hemodialysis treatment in cefepime-induced neurotoxicity: Case report, pharmacokinetic modeling, and review of the literature.
Mani L.Y., Kissling S., Viceic D., Vogt B., Burnier M., Buclin T., Renard D., 2015/07. Hemodialysis International. International Symposium On Home Hemodialysis, 19 (2) pp. 333-343. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_95626566C721]
 
Urinary angiotensinogen and salt sensitivity of blood pressure: the challenge of finding biomarkers of salt-sensitivity.
Burnier M., 2015/07. Journal of Hypertension, 33 (7) pp. 1368-1370.
[DOI][WoS][Pmid][serval:BIB_56DC5F0C42C4]
 
1C.06: Ambulatory pulse pressure is negatively associated with excretions of urinary caffeine and its metabolites
Guessous I., Pruijm M., Ponte B., Ehret G., Ansermot N., Vuistiner P., Staessen J.A., Gu Y.M., Paccaud F., Mohaupt M.G. et al., 2015/06., ESH 2015: 25th European meeting on hypertension and cardiovascular protection, 12-15 June 2015, Milan (Italy) pp. e10-e11 dans J Hypertension. Peer-reviewed.
[DOI][Pmid][serval:BIB_408916E57FC5]
 
1D.03: Inactive matrix GLA protein is associated with renal resistive index in a population-based study
Pivin E., Pruijm M., Ackermann D., Guessous I., Ehret G., Pechère-Bertschi A., Paccaud F., Mohaupt M., Vermeer C., Staessen J.A. et al., 2015/06., ESH 2015: 25th European meeting on hypertension and cardiovascular protection, 12-15 June 2015, Milan (Italy) pp. e15 dans J Hypertension. Peer-reviewed.
[DOI][Pmid][serval:BIB_D7E107F3884C]
 
4B.05: Plasma Lasma copeptin is associated with insulin resistance in a Swiss population-based study
Canivell S., Ponte B., Pruijm M., Ackermann D., Guessous I., Ehret G., Paccaud F., Pechere-Bertschi A., Mohaupt M., Vogt B. et al., 2015/06., ESH 2015: 25th European meeting on hypertension and cardiovascular protection, 12-15 June 2015, Milan (Italy) pp. e54 dans J Hypertension. Peer-reviewed.
[DOI][Pmid][serval:BIB_8A5B9531252B]
 
5C.09: Heritability of renal function parameters and electrolyte levels in the Swiss population
Moulin F., Ponte B., Pruijm M., Ackermann D., Guessous I., Ehret G., Bonny O., Pechere-Bertschi A., Staessen J.A., Paccaud F. et al., 2015/06., ESH 2015: 25th European meeting on hypertension and cardiovascular protection, 12-15 June 2015, Milan (Italy) pp. e70 dans J Hypertension. Peer-reviewed.
[DOI][Pmid][serval:BIB_200012B63E92]
 
9C.09: TREATMENT WITH CANDESARTAN UNMASKS HIGHER URINARY NOREPINEPHRINE EXCRETION IN WHITE COAT HYPERTENSIVE PATIENTS COMPARED TO HEALTHY NORMOTENSIVE PARTICIPANTS.
Vakilzadeh N., Grouzmann E., Maillard M., Burnier M., Wuerzner G., 2015/06. pp. e125 dans Journal of Hypertension V. Peer-reviewed.
[DOI][Pmid][serval:BIB_5FE06E782905]
 
Association of urinary calcium excretion with serum calcium and vitamin D levels.
Rathod A., Bonny O., Guessous I., Suter P.M., Conen D., Erne P., Binet I., Gabutti L., Gallino A., Muggli F. et al., 2015/03/06. Clinical journal of the American Society of Nephrology, 10 (3) pp. 452-462. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2E85E3E779F3]
 
Que peut-on attendre de la dialyse dans le futur? [What to expect from dialysis in the future?]
Schneider M., Kissling S., Saucy F., Burnier M., Pruijm M., 2015/02/25. Revue medicale suisse, 11 (463) pp. 514-516,518-520. Peer-reviewed.
[Pmid][serval:BIB_D3879D690DB8]
 
L'hémodiayse intermittente, irremplaçable dans certains cas d'intoxications sévères [Intermittent hemodialysis, irreplaceable in specific cases of severe poisoning].
Ventresca M., Teta D., Burnier M., Kissling S., 2015/02. Revue Médicale Suisse, 11 (463) pp. 499-504.
[Pmid][serval:BIB_EC6E5C623CB2]
 
[112-POS] : Increased post-partum prevalence of hypertension and renal dysfunction after preeclampsia
Ditisheim A., Ponte B., Wuerzner G., Burnier M., Boulvain M., Pechère-Bertschi A., 2015. pp. 60-61 dans Abstracts from the XIXth World Congress of the ISSHP, 26-29 October 2014, New Orleans, LA, USA.
[DOI][Pmid][serval:BIB_97FBA38B5F53]
A prospective observational study comparing a non-operator dependent automatic PWV analyser to pulse pressure, in assessing arterial stiffness in hemodialysis.
Salvadé I., Schätti-Stählin S., Violetti E., Schönholzer C., Cereghetti C., Zwahlen H., Berwert L., Burnier M., Gabutti L., 2015. Bmc Nephrology, 16 (1) p. 62. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B9CAA9B324E5]
 
Antihypertensive Combination Treatment: State of the Art.
Burnier M., 2015. Current Hypertension Reports, 17 (7) p. 51. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_20D7447BC5F6]
 
Associations of ambulatory blood pressure with urinary caffeine and caffeine metabolite excretions.
Guessous I., Pruijm M., Ponte B., Ackermann D., Ehret G., Ansermot N., Vuistiner P., Staessen J., Gu Y., Paccaud F. et al., 2015. Hypertension, 65 (3) pp. 691-696. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C5A6ADCBDFAD]
 
Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
Ewen S., Meyer M.R., Cremers B., Laufs U., Helfer A.G., Linz D., Kindermann I., Ukena C., Burnier M., Wagenpfeil S. et al., 2015. Clinical Research In Cardiology : Official Journal of the German Cardiac Society, 104 (12) pp. 1097-1105. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_697C420670D8]
 
Cadmium body burden of the Swiss population.
Jenny-Burri J., Haldimann M., Brüschweiler B.J., Bochud M., Burnier M., Paccaud F., Dudler V., 2015. Food Additives and Contaminants. Part A, Chemistry, Analysis, Control, Exposure and Risk Assessment, 32 (8) pp. 1265-1272. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DAA73D49FCD5]
 
Comparative Effect of a Renin Inhibitor and a Thiazide Diuretic on Renal Tissue Oxygenation in Hypertensive Patients.
Vakilzadeh N., Muller M.E., Forni V., Milani B., Hoffman L., Piskunowicz M., Maillard M., Zweiacker C., Pruijm M., Burnier M., 2015. Kidney and Blood Pressure Research, 40 (5) pp. 542-554. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E3EA18BB8ACD]
 
Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study.
Ponte B., Pruijm M., Ackermann D., Vuistiner P., Guessous I., Ehret G., Alwan H., Youhanna S., Paccaud F., Mohaupt M. et al., 2015. Journal of the American Society of Nephrology : Jasn, 26 (6) pp. 1415-1425. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_71C4D07716AD]
Drug adherence in chronic kidney diseases and dialysis.
Burnier M., Pruijm M., Wuerzner G., Santschi V., 2015. Nephrology, Dialysis, Transplantation, 30 (1) pp. 39-44. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_956823FFF7CC]
Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure.
Phan O., Maillard M., Malluche H.H., Stehle J.C., Funk F., Burnier M., 2015. Biomed Research International, 2015 p. 515606. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C757FFF0A021]
ENaC activity in collecting ducts modulates NCC in cirrhotic mice.
Mordasini D., Loffing-Cueni D., Loffing J., Beatrice R., Maillard M.P., Hummler E., Burnier M., Escher G., Vogt B., 2015. Pflügers Archiv : European Journal of Physiology, 467 (12) pp. 2529-2539. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EEAFFA21DE0F]
 
Inactive Matrix Gla-Protein is associated with arterial stiffness in an adult population-based study
Pivin E., Ponte B., Pruijm M., Ackermann D., Guessous I., Ehret G., Liu Y.P., Drummen N.E., Knapen M.H., Pechere-Bertschi A. et al., 2015. Hypertension, 66 (1) pp. 85-92. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5A885D1E1E5B]
 
Meta-analysis of correlated traits via summary statistics from GWASs with an application in hypertension
Zhu X., Feng T., Tayo B.O., Liang J., Young J.H., Franceschini N., Smith J.A., Yanek L.R., Sun Y.V., Edwards T.L. et al., 2015. American Journal of Human Genetics, 96 (1) pp. 21-36. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_75E1E9707098]
Modulation of genetic associations with serum urate levels by body-mass-index in humans.
Huffman J.E., Albrecht E., Teumer A., Mangino M., Kapur K., Johnson T., Kutalik Z., Pirastu N., Pistis G., Lopez L.M. et al., 2015. Plos One, 10 (3) pp. e0119752. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E8D96115B4D8]
New genetic loci link adipose and insulin biology to body fat distribution.
Shungin D., Winkler T.W., Croteau-Chonka D.C., Ferreira T., Locke A.E., Mägi R., Strawbridge R.J., Pers T.H., Fischer K., Justice A.E. et al., 2015. Nature, 518 (7538) pp. 187-196. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_10C25BFE14DB]
 
Obstructive Sleep Apnea Severity and Overnight Body Fluid Shift before and after Hemodialysis.
Ogna A., Forni Ogna V., Mihalache A., Pruijm M., Halabi G., Phan O., Cornette F., Bassi I., Haba Rubio J., Burnier M. et al., 2015. Clinical Journal of the American Society of Nephrology : Cjasn, 10 (6) pp. 1002-1010. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_24E31BAB288B]
 
Pathophysiology of Hypertension
Burnier Michel, Wuerzner Grégoire, 2015. 15.
[DOI][serval:BIB_6565AF261F40]
 
Performance of parental history for the targeted screening of hypertension in children.
Bloetzer C., Paccaud F., Burnier M., Bovet P., Chiolero A., 2015. Journal of Hypertension, 33 (6) pp. 1167-1173. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0E2331368CD6]
 
Post-partum persistence of abnormal circadian pattern of blood pressure after preeclampsia [109-POS]
Ditisheim A., Ponte B., Wuerzner G., Burnier M., Boulvain M., Pechère-Bertschi A., 2015/01. p. 59 dans XIXth World Congress for the Study of Hypertension in Pregnancy Preeclampsia/Hypertension: Future Risks and Novel Therapies, International Journal of Women's Cardiovascular Health.
[DOI][Pmid][serval:BIB_90B6408AC69D]
Prevalence and Diagnostic Approach to Sleep Apnea in Hemodialysis Patients: A Population Study.
Forni Ogna V., Ogna A., Pruijm M., Bassi I., Zuercher E., Halabi G., Phan O., Bullani R., Teta D., Gauthier T. et al., 2015. Biomed Research International, 2015 p. 103686.
[URN][DOI][WoS][Pmid][serval:BIB_FD7B90AC94CA]
Prevalence of iodine inadequacy in Switzerland assessed by the estimated average requirement cut-point method in relation to the impact of iodized salt.
Haldimann M., Bochud M., Burnier M., Paccaud F., Dudler V., 2015. Public Health Nutrition, 18 (8) pp. 1333-1342. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DA413027D74B]
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design.
Mahfoud F., Böhm M., Azizi M., Pathak A., Durand Zaleski I., Ewen S., Tsioufis K., Andersson B., Blankestijn P.J., Burnier M. et al., 2015. European Heart Journal, 36 (33) pp. 2219-2227. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_460EB6ADDAF6]
Salt, blood pressure and cardiovascular risk : what is the most adequate preventive strategy? A Swiss perspective
Burnier M., Wuerzner G., Bochud M., 2015. Frontiers in Physiology, 6 p. 227. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_50BB266EB559]
2014
 
Hypertension et adhérence thérapeutique: un challenge de tous les jours [Hypertension and medication compliance: a challenge every day]
Vuignier Y., Burnier M., Waeber B., Wuerzner G., 2014/12/10. Praxis, 103 (25) pp. 1515-1519. Peer-reviewed.
[DOI][Pmid][serval:BIB_E33B5272F7E7]
 
Hypertension in Chronic Kidney Disease - Role of Arterial Calcification and Impact on Treatment.
Phan O., Burnier M., Wuerzner G., 2014/12. European cardiology, 9 (2) pp. 115-119. Peer-reviewed.
[DOI][Pmid][serval:BIB_E57B54E0E887]
Pioglitazone improves fat distribution, the adipokine profile and hepatic insulin sensitivity in non-diabetic end-stage renal disease subjects on maintenance dialysis: a randomized cross-over pilot study.
Zanchi A., Tappy L., Lê K.A., Bortolotti M., Theumann N., Halabi G., Gauthier T., Mathieu C., Tremblay S., Bertrand P.C. et al., 2014/10. Plos One, 9 (10) pp. e109134. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1D97934B1629]
 
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial.
Zanchetti A., Liu L., Mancia G., Parati G., Grassi G., Stramba-Badiale M., Silani V., Bilo G., Corrao G., Zambon A. et al., 2014/09. Journal of hypertension, 32 (9) pp. 1888-1897.
[DOI][Pmid][serval:BIB_D29ACD0470B8]
 
Meédicaments: une cause sous-estimée d'hypertension artérielle [Drugs: an underestimated cause of arterial hypertension].
Serveaux M., Burnier M., Pruijm M., 2014/09. Revue Médicale Suisse, 10 (441) pp. 1661-2, 1664-5.
[Pmid][serval:BIB_D05EC0C0C042]
 
Nouveaux aspects de la prise en charge de l'hypertension artérielle chez le patient insuffisant rénal chronique [New aspects of hypertension management in patients with chronic kidney disease].
Vakilzadeh N., Phan O., Ogna V.F., Burnier M., Wuerzner G., 2014/09. Revue Médicale Suisse, 10 (441) pp. 1668-1672.
[Pmid][serval:BIB_D1A2B0FA6384]
Prevalence of obesity and overweight and associated nutritional factors in a population-based Swiss sample: an opportunity to analyze the impact of three different European cultural roots.
Ogna A., Forni Ogna V., Bochud M., Paccaud F., Gabutti L., Burnier M., Swiss Survey on Salt Group, 2014/08. European journal of nutrition, 53 (5) pp. 1281-1290. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6C23A1B8A38F]
 
Assessment of subjective and hemodynamic tolerance of different high- and low-flux dialysis membranes in patients undergoing chronic intermittent hemodialysis: a randomized controlled trial.
Bianchi G., Salvadé V., Lucchini B., Schätti-Stählin S., Salvadé I., Burnier M., Gabutti L., 2014/05. Hemodialysis International. International Symposium on Home Hemodialysis, 18 (4) pp. 825-834.
[DOI][WoS][Pmid][serval:BIB_27980115BCDC]
Determinants of renal tissue oxygenation as measured with BOLD-MRI in chronic kidney disease and hypertension in humans.
Pruijm M., Hofmann L., Piskunowicz M., Muller M.E., Zweiacker C., Bassi I., Vogt B., Stuber M., Burnier M., 2014/04. Plos One, 9 (4) pp. e95895. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0CA1F4EDF7F3]
 
Interprétation de la volémie dans l'insuffisance rénale aiguë [Interpretation of volemia in acute kidney injury].
Serveaux M., Burnier M., Kissling S., 2014/02. Revue Médicale Suisse, 10 (419) pp. 474-6, 478-9.
[Pmid][serval:BIB_41921E070392]
 
Maladies vasculaires rares [Rare vascular diseases].
Calanca L., Depairon M., Tribout B., Aebischer N., Burnier M., Fellmann F., Lazor R., Mazzolai L., 2014/02. Revue Médicale Suisse, 10 (416) pp. 347-50, 352.
[Pmid][serval:BIB_D39C18EC277E]
 
Nouvelles approches dans l'insuffisance rénale aiguë et les vascularites [New approaches in acute kidney insufficiency and vasculitides ].
Burnier M., Martin P.Y., 2014/02. Revue Médicale Suisse, 10 (419) pp. 467-468.
[Pmid][serval:BIB_5E2A641238C2]
 
Risques rénaux des compléments alimentaires: une cause ignorée [Renal risks of dietary complements: a forgotten cause].
Dori O., Humbert A., Burnier M., Teta D., 2014/02. Revue Médicale Suisse, 10 (419) pp. 498-503.
[Pmid][serval:BIB_C9E3F298663E]
 
Ambulatory Blood Pressure and Adherence Monitoring: Diagnosing Pseudoresistant Hypertension.
Burnier M., Wuerzner G., 2014. Seminars in Nephrology, 34 (5) pp. 498-505. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1E0D6D5B09C9]
 
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence.
Zanchetti A., Liu L., Mancia G., Parati G., Grassi G., Stramba-Badiale M., Silani V., Bilo G., Corrao G., Zambon A. et al., 2014. Journal of Hypertension, 32 (9) pp. 1741-1750. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6B00E6772E4C]
Blood pressure and physical activity : time to move (on)
Wuerzner G., Bochud M., Burnier M., 2014. American Journal of Hypertension, 27 (8) p. 1125. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3AC2B1A0AABF]
Blood pressure changes after renal denervation at 10 European expert centers.
Persu A., Jin Y., Azizi M., Baelen M., Völz S., Elvan A., Severino F., Rosa J., Adiyaman A., Fadl Elmula F.E. et al., 2014. Journal of Human Hypertension, 28 (3) pp. 150-156. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_69AD7F628235]
 
Chronic kidney disease: Should sodium intake be restricted in patients with CKD?
Burnier M., Wuerzner G., 2014. Nature Reviews. Nephrology, 10 (7) pp. 363-364.
[DOI][WoS][Pmid][serval:BIB_D94F66E14666]
 
Clinical and biological determinants of kidney outcomes in a population-based cohort study
Guessous I., Ponte B., Marques-Vidal P., Paccaud F., Gaspoz J.M., Burnier M., Waeber G., Vollenweider P., Bochud M., 2014. Kidney and Blood Pressure Research, 39 (1) pp. 74-85. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_100057102FD2]
 
Comparisons of serum vitamin d levels, status, and determinants in populations with and without chronic kidney disease not requiring renal dialysis: a 24-hour urine collection population-based study.
Guessous I., McClellan W., Kleinbaum D., Vaccarino V., Zoller O., Theler J.M., Paccaud F., Burnier M., Bochud M., Swiss Survey on Salt Group, 2014. Journal of Renal Nutrition, 24 (5) pp. 303-312. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_50B6A25089E3]
 
Eligibility for renal denervation: experience at 11 European expert centers.
Persu A., Jin Y., Baelen M., Vink E., Verloop W.L., Schmidt B., Blicher M.K., Severino F., Wuerzner G., Taylor A. et al., 2014. Hypertension, 63 (6) pp. 1319-1325.
[DOI][WoS][Pmid][serval:BIB_29FDFC4186D3]
Epidemiology of Masked and White-Coat Hypertension: The Family-Based SKIPOGH Study.
Alwan H., Pruijm M., Ponte B., Ackermann D., Guessous I., Ehret G., Staessen J.A., Asayama K., Vuistiner P., Younes S.E. et al., 2014. Plos One, 9 (3) pp. e92522. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D41F9D70978B]
 
Etiological and Pathophysiological Aspects of Hypertension: Other Humoral-Endocrine Factors
Burnier M., 2014. pp. 149-158 dans Mancia G., Grassi G., Redon G (eds.) Manual of hypertension of the European Society of Hypertension chap. 16, CRC Press.
[serval:BIB_E95745F2B4C9]
 
Hyperresponders vs. nonresponder patients after renal denervation: do they differ?
Persu A., Azizi M., Jin Y., Volz S., Rosa J., Fadl Elmula F.E., Pechere-Bertschi A., Burnier M., Mark P.B., Elvan A. et al., 2014. Journal of Hypertension, 32 (12) pp. 2422-7; discussion 2427. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1DDE970B2389]
Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials.
Santschi V., Chiolero A., Colosimo A.L., Platt R.W., Taffé P., Burnier M., Burnand B., Paradis G., 2014. Journal of the American Heart Association, 3 (2) pp. e000718. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5843DF507CB0]
 
Managing 'resistance': is adherence a target for treatment?
Burnier M., 2014. Current Opinion in Nephrology and Hypertension, 23 (5) pp. 439-443.
[DOI][WoS][Pmid][serval:BIB_728A6385CA2C]
 
Medical Treatment of Hypertension: Monotherapy and Combination Therapy
M. Burnier , G. Wuerzner , B. Waeber , 2014. pp. 309-318 dans Mancia G., Grassi G., Redon G (eds.) Manual of hypertension of the European Society of Hypertension, CRC Press.
[serval:BIB_04CBA45353CF]
 
Performance of blood pressure-to-height ratio at a single screening visit for the identification of hypertension in children.
Outdili Z., Marti-Soler H., Simonetti G.D., Bovet P., Paccaud F., Burnier M., Paradis G., Chiolero A., 2014. Journal of Hypertension, 32 (5) pp. 1068-74; discussion 1074. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5D6893C6A906]
 
Reference values and factors associated with renal resistive index in a family-based population study.
Ponte B., Pruijm M., Ackermann D., Vuistiner P., Eisenberger U., Guessous I., Rousson V., Mohaupt M.G., Alwan H., Ehret G. et al., 2014. Hypertension, 63 (1) pp. 136-142. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DDF68E1C8890]
 
Response to maximizing treatment adherence: physician-patient partnerships vs procedures.
Burnier M., Wuerzner G., Boudier H.S., Urquhart J., 2014. Hypertension, 63 (2) pp. e8.
[WoS][Pmid][serval:BIB_77212E404F39]
State-of-the-art treatment of hypertension: established and new drugs.
Burnier M., Vuignier Y., Wuerzner G., 2014. European Heart Journal, 35 (9) pp. 557-562. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_45A42B7B60D6]
Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensus.
Wuerzner G., Muller O., Erne P., Cook S., Sudano I., Lüscher T.F., Noll G., Kaufmann U., Rickli H., Waeber B. et al., 2014. Swiss Medical Weekly, 144 pp. w13913.
[URN][DOI][Pmid][serval:BIB_B279E13B1B71]
2013
 
No use for waist-for-height ratio in addition to body mass index to identify children with elevated blood pressure.
Chiolero A., Paradis G., Maximova K., Burnier M., Bovet P., 2013/07. Blood Pressure, 22 (1) pp. 17-20. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_907C0FB3DCA0]
 
Verbessern Arzneimittel-Einnahmehilfen die Compliance [Do drug taking aids improve compliance?].
Santschi V., Burnier M., Peytremann-Bridevaux I., 2013/06. Praxis, 102 (13) pp. 807-808.
[DOI][Pmid][serval:BIB_5922D2C9F9D5]
 
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Mancia G., Fagard R., Narkiewicz K., Redón J., Zanchetti A., Böhm M., Christiaens T., Cifkova R., De Backer G., Dominiczak A. et al., 2013. Journal of Hypertension, 31 (7) pp. 1281-1357. Peer-reviewed.
[DOI][Pmid][serval:BIB_FA1435B1D6AF]
Association of calcemia and serum vitamin D with 24H-urinary calcium excretion in a swiss population-based study
Rathod A., Bonny O., Guessous I., Suter P.M., Conen D., Erne P., Péchère-Bertschi A., Paccaud F., Burnier M., Bochud M., 2013. dans Swiss Public Health Conference 2013.
[URN][serval:BIB_ECBB1BF0083C]
 
Blockade of the renin-angiotensin system and renal tissue oxygenation as measured with BOLD-MRI in patients with type 2 diabetes.
Pruijm M., Hofmann L., Zanchi A., Maillard M., Forni V., Muller M.E., Wuerzner G., Vogt B., Stuber M., Burnier M., 2013. Diabetes Research and Clinical Practice, 99 (2) pp. 136-144. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EB1FB150E41F]
 
Blockade of the Renin-Angiotensin system in hypertensive patients with atherosclerotic renal artery stenosis.
Jarraya F., Pruijm M., Wuerzner G., Burnier M., 2013. Current Hypertension Reports, 15 (5) pp. 497-505. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D83473F0E104]
 
Calcifications vasculaires et déficit en vitamine K: un facteur de risque modifiable dans l'insuffisance rénale chronique [Vascular calcifications and vitamin K deficiency: a modifiable risk factor in chronic kidney disease].
Phan O., Burnier M., 2013. Revue Médicale Suisse, 9 (375) pp. 451-455.
[Pmid][serval:BIB_7C0C1CCD579B]
Clinical benefits of an adherence monitoring program in the management of secondary hyperparathyroidism with cinacalcet: results of a prospective randomized controlled study.
Forni Ogna V., Pruijm M., Zweiacker C., Wuerzner G., Tousset E., Burnier M., 2013. Biomed Research International, 2013 p. 104892.
[URN][DOI][WoS][Pmid][serval:BIB_1C759E046A85]
Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression.
Trudu M., Janas S., Lanzani C., Debaix H., Schaeffer C., Ikehata M., Citterio L., Demaretz S., Trevisani F., Ristagno G. et al., 2013. Nature Medicine, 19 (12) pp. 1655-1660.
[URN][DOI][WoS][Pmid][serval:BIB_C399FC2ECDDE]
Common variants associated with plasma triglycerides and risk for coronary artery disease.
Do R., Willer C.J., Schmidt E.M., Sengupta S., Gao C., Peloso G.M., Gustafsson S., Kanoni S., Ganna A., Chen J. et al., 2013. Nature Genetics, 45 (11) pp. 1345-1352.
[URN][DOI][WoS][Pmid][serval:BIB_5CA22C7D515E]
Determinants and burden of chronic kidney disease in the population-based CoLaus study: a cross-sectional analysis.
Ponte B., Pruijm M., Marques-Vidal P., Martin P.Y., Burnier M., Paccaud F., Waeber G., Vollenweider P., Bochud M., 2013. Nephrology, Dialysis, Transplantation, 28 (9) pp. 2329-2339. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3AE2E237896D]
 
Dialyse et écologie: est-il possible de faire mieux à l'avenir [Dialysis and ecology: can we do better in the future?].
Vuignier Y., Pruijm M., Jarrayah F., Burnier M., 2013. Revue Médicale Suisse, 9 (375) pp. 468-472.
[Pmid][serval:BIB_56923B136FD8]
Discovery and refinement of loci associated with lipid levels.
Global Lipids Genetics Consortium, Willer C.J., Willer C.J., Schmidt E.M., Sengupta S., Peloso G.M., Gustafsson S., Kanoni S., Ganna A., Chen J. et al., 2013. Nature Genetics, 45 (11) pp. 1274-1283.
[URN][DOI][WoS][Pmid][serval:BIB_4F479093D7BD]
 
Effect of dark chocolate on renal tissue oxygenation as measured by BOLD-MRI in healthy volunteers.
Pruijm M., Hofmann L., Charollais-Thoenig J., Forni V., Maillard M., Coristine A., Stuber M., Burnier M., Vogt B., 2013. Clinical Nephrology, 80 (9) pp. 211-217.
[DOI][WoS][Pmid][serval:BIB_CC4322D153E9]
Factors associated with 24-hour urinary volume: the Swiss salt survey.
Schoen T., Blum J., Paccaud F., Burnier M., Bochud M., Conen D., Swiss Survey on Salt investigators, 2013. Bmc Nephrology, 14 (246) p. 246.
[URN][DOI][WoS][Pmid][serval:BIB_0B7980CDD959]
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.
Köttgen A., Albrecht E., Teumer A., Vitart V., Krumsiek J., Hundertmark C., Pistis G., Ruggiero D., O'Seaghdha C.M., Haller T. et al., 2013. Nature Genetics, 45 (2) pp. 145-154. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_772703318942]
 
Genome-wide association analysis of blood-pressure traits in African-ancestry individuals reveals common associated genes in African and non-African populations.
Franceschini N., Fox E., Zhang Z., Edwards T.L., Nalls M.A., Sung Y.J., Tayo B.O., Sun Y.V., Gottesman O., Adeyemo A. et al., 2013. American Journal of Human Genetics, 93 (3) pp. 545-554.
[DOI][WoS][Pmid][serval:BIB_8CA92D98BCC9]
Hemodialysis for cefepime intoxication: A case report
Mani L.Y., Kissling S., Burnier M., Buclin T., Renard D., 2013. pp. e24 dans 11th Conference of the European Association for Clinical Pharmacology and Therapeutics, Clinical Therapeutics.
[URN][serval:BIB_E4B72FAAFE84]
Heritability of blood pressure in the swiss population: the family-based skipogh study
Alwan H., Ehret G., Ponte B., Pruijm M., Ackermann D., Guessous I., Pechère-Bertschi A., Paccaud F., Burnier M, Bochud M., 2013. dans Swiss Public Health Conference 2013.
[URN][serval:BIB_D9C8C0F19244]
Heritability, determinants and reference values of renal length: a family-based population study.
Pruijm M., Ponte B., Ackermann D., Vuistiner P., Paccaud F., Guessous I., Ehret G., Eisenberger U., Mohaupt M., Burnier M. et al., 2013. European Radiology, 23 (10) pp. 2899-2905. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0208A4ED3843]
 
Hyperaldostéronisme primaire sur adénome ou hyperplasie de la surrénale: opérer ou non [Primary hyperaldosteronism with adrenal adenoma or hyperplasia: surgical case or not?].
Muller M.E., Doenz F., Matter M., Wuerzner G., Burnier M., 2013. Revue Médicale Suisse, 9 (397) pp. 1633-1638.
[Pmid][serval:BIB_AB8114993EC9]
 
Hypertension: les nouvelles recommandations européennes sont arrivées ! TA l 140/90 mmHg pour tous [Hypertension: new European guidelines have have arrived! BP <140/90 mmHg for all].
Burnier M., Bertschi A.P., Waeber B., 2013. Revue Médicale Suisse, 9 (397) p. 1611.
[Pmid][serval:BIB_0E643C9BFF30]
 
Impact de la consommation de sel sur la santé: les croyances de la population suisse [Impact of salt intake on health: beliefs of the Swiss population].
Ditisheim A., Muradbegovic E., Bochud M., Burnier M., Pechère-Bertschi A., 2013. Revue Médicale Suisse, 9 (397) pp. 1613-1616.
[Pmid][serval:BIB_70A0C71C6C9C]
 
Increased salt sensitivity of ambulatory blood pressure in women with a history of severe preeclampsia.
Martillotti G., Ditisheim A., Burnier M., Wagner G., Boulvain M., Irion O., Pechère-Bertschi A., 2013. Hypertension, 62 (4) pp. 802-808.
[DOI][WoS][Pmid][serval:BIB_DE8F753CB297]
 
Inflammatory markers and blood pressure: sex differences and the effect of fat mass in the CoLaus Study.
Pruijm M., Vollenweider P., Mooser V., Paccaud F., Preisig M., Waeber G., Marques-Vidal P., Burnier M., Bochud M., 2013. Journal of Human Hypertension, 27 (3) pp. 169-175.
[DOI][WoS][Pmid][serval:BIB_08B527D955B7]
 
La guerre du sel : utilité et limites des revues Cochrane
Bochud M., Burnier M., Paccaud F., 2013. Revue Médicale Suisse, 9 pp. 2192-2193.
[serval:BIB_1DD312E4FFBE]
 
La vitesse de l'onde de pouls et la pression artérielle centrale devraient-elles être mesurées chez les patients hypertendus
Muller M.E., Zimmerli L., Burnier M., Wuerzner G., 2013. Praxis, 102 (9) pp. 529-533.
[DOI][Pmid][serval:BIB_FC6595146DB8]
 
Measuring, analyzing, and managing drug adherence in resistant hypertension.
Burnier M., Wuerzner G., Struijker-Boudier H., Urquhart J., 2013. Hypertension, 62 (2) pp. 218-225.
[DOI][WoS][Pmid][serval:BIB_14FD3B18E2AD]
 
Oscillometric blood pressure reference values in children.
Chiolero Arnaud, Bovet Pascal, Burnier Michel, 2013. Journal of Hypertension, 31 (2) p. 426. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D51216FC5CDB]
 
PA21, a New Iron-Based Noncalcium Phosphate Binder, Prevents Vascular Calcification in Chronic Renal Failure Rats.
Phan O., Maillard M., Peregaux C., Mordasini D., Stehle J.C., Funk F., Burnier M., 2013. Journal of Pharmacology and Experimental Therapeutics, 346 (2) pp. 281-289.
[DOI][WoS][Pmid][serval:BIB_9B3FF62DF72B]
 
Patients with non-insulin depending diabetes mellitus and metabolic syndrome are suboptimal treated in swiss primary care.
Schäfer H.H., de Villiers J.D., Lotze U., Sivukhina E., Burnier M., Noll G., Theus G.R., Dieterle T., 2013. Clinical and Experimental Hypertension, 35 (7) pp. 496-505.
[DOI][WoS][Pmid][serval:BIB_0D7BC4D6702A]
 
Péritonite infectieuse en dialyse péritonéale: une complication trop redoutée [Infectious peritonitis in peritoneal dialysis: an over-emphasized complication].
Vakilzadeh N., Burnier M., Halabi G., 2013. Revue Médicale Suisse, 9 (375) pp. 446-450.
[Pmid][serval:BIB_A1A3E9F1BC32]
 
Rein et tabac : revue de la littérature et mise au point [Kidney and smoking: literature review and focus].
Phan O., El Housseini Y., Burnier M., Vogt B., 2013. Néphrologie and Thérapeutique, 9 (2) pp. 67-72.
[DOI][WoS][Pmid][serval:BIB_7D329674A757]
 
Renal protection with calcium antagonists: the role of lercanidipine.
Burnier M., 2013. Current Medical Research and Opinion, 29 (12) pp. 1727-1735.
[DOI][WoS][Pmid][serval:BIB_1F9CA1ED8A2E]
 
Renal tissue oxygenation in essential hypertension and chronic kidney disease.
Pruijm M., Hofmann L., Vogt B., Muller M.E., Piskunowicz M., Stuber M., Burnier M., 2013. International Journal of Hypertension, 2013 (696598) p. 696598.
[DOI][Pmid][serval:BIB_7D94C32E9023]
 
Residual effect of renal denervation in patients with truly resistant hypertension.
Persu A., Azizi M., Burnier M., Staessen J.A., 2013. Hypertension, 62 (3) pp. 450-452.
[DOI][WoS][Pmid][serval:BIB_398702463878]
Response to "assessment of blood pressure dipping: is the evaluation method important?".
Wuerzner G., Burnier M., 2013. American Journal of Hypertension, 26 (8) p. 1054.
[URN][DOI][WoS][Pmid][serval:BIB_F93C26A98096]
Reticulocyte dynamic and hemoglobin variability in hemodialysis patients treated with Darbepoetin alfa and C.E.R.A.: a randomized controlled trial.
Forni V., Bianchi G., Ogna A., Salvadé I., Vuistiner P., Burnier M., Gabutti L., 2013. BMC Nephrology, 14 (157) pp. 1-10. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BFEA80800218]
Step count is associated with lower nighttime systolic blood pressure and increased dipping.
Wuerzner G., Bochud M., Zweiacker C., Tremblay S., Pruijm M., Burnier M., 2013. American Journal of Hypertension, 26 (4) pp. 527-534.
[URN][DOI][WoS][Pmid][serval:BIB_742A598070BD]
 
Stimulated sweating as a therapy to reduce interdialytic weight gain and improve potassium balance in chronic hemodialysis patients: a pilot study.
Pruijm M., El-Housseini Y., Mahfoudh H., Jarraya F., Hachicha J., Teta D., Burnier M., 2013. Hemodialysis International., 17 (2) pp. 240-248.
[DOI][WoS][Pmid][serval:BIB_5A9573BEE163]
 
Treatment of Resistant Hypertension. Which Additional Antihypertensive Drugs?
Burnier M., Pechère Bertschi A., Wuerzner G., 2013. pp. 115-126 dans Mancia G. (eds.) Resistant Hypertension : Epidemiology, Pathophysiology, Diagnosis and Treatment, Springer.
[DOI][serval:BIB_0295D71CC12B]
2012
Estimation of glomerular filtration rate in hospitalised patients: are we overestimating renal function?
Frank M., Guarino-Gubler S., Burnier M., Maillard M., Keller F., Gabutti L., 2012/12/19. Swiss medical weekly, 142 pp. w13708. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_22A5E24403C6]
 
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
Parving H.H., Brenner B.M., McMurray J.J., de Zeeuw D., Haffner S.M., Solomon S.D., Chaturvedi N., Persson F., Desai A.S., Nicolaides M. et al., 2012/12. New England Journal of Medicine, 367 (23) pp. 2204-2213. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AA678180CBF9]
 
High prevalence of anti-apolipoprotein/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage.
Pruijm M., Schmidtko J., Aho A., Pagano S., Roux-Lombard P., Teta D., Burnier M., Vuilleumier N., 2012/12. Therapeutic Apheresis and Dialysis, 16 (6) pp. 588-594. Peer-reviewed.
[DOI][Pmid][serval:BIB_4FE19EA9B0E6]
Vitamin D levels and associated factors: a population-based study in Switzerland.
Guessous I., Dudler V., Glatz N., Theler J.M., Zoller O., Paccaud F., Burnier M., Bochud M., Swiss Survey on Salt Group, 2012/11. Swiss Medical Weekly, 142 p. 0.
[URN][DOI][WoS][Pmid][serval:BIB_6364F33C5A95]
 
Améliorer la prise en charge de l'hypertension arterielle en favorisant la collaboration avec les pharmaciens et les infirmières [Team-based care involving pharmacists and nurses to improve the management of hypertension].
Santschi V., Wuerzner G., Chiolero A., Burnand B., Paradis G., Burnier M., 2012/09. Revue médicale suisse, 8 (353) pp. 1694-6, 1698.
[Pmid][serval:BIB_518B665EC473]
 
Réduction de la consommation de sel: opportunité, impact et stratégies. [Population reduction of salt consumption: opportunities, impact and strategies].
Bochud M., Marques-Vidal P., Burnier M., Paccaud F., 2012/07. Revue médicale suisse, 8 (348) pp. 1443-1447.
[Pmid][serval:BIB_65C8A0D0B6CD]
 
Hypertoniebehandlung bei Nierenarterienstenose [Hypertension therapy in patients with renal artery stenosis].
Vogt B., Maillard M., Burnier M., 2012/05. Therapeutische Umschau. Revue Thérapeutique, 69 (5) pp. 279-281.
[DOI][Pmid][serval:BIB_E5DF3D4282AE]
 
Blocage du système rénine-angiotensine: il ne faut pas abuser des bonnes choses [Renin angiotensin system inhibitors: too much of a good thing can be dangerous].
Burnier M., Martin P.Y., 2012/02. Revue Médicale Suisse, 8 (330) pp. 443-444.
[Pmid][serval:BIB_AA0D608E5520]
 
Target blood pressure attainment with antihypertensive therapy in Swiss primary care.
Hendrik Schäfer H., Sudano I., Theus G.R., Noll G., Burnier M., 2012/02. Blood Pressure, 21 (4) pp. 211-219.
[DOI][WoS][Pmid][serval:BIB_93D3C9B0AEE3]
 
A randomized controlled trial to assess effectiveness of polypill in primary health care in Seychelles
Bovet P., Gedeon J., Burnier M., Paccaud F., 2012. dans Global Summit on Combination Polypharmacy for Cardiovascular Disease.
[serval:BIB_FFE521CD4029]
 
Amyloïdose rénale [Renal amyloidosis].
Cuchard P., Cuchard R., Rotman S., Burnier M., Gauthier T., 2012. Revue Médicale Suisse, 8 (330) pp. 446-451.
[Pmid][serval:BIB_A04BBD2F5090]
 
Antihypertensive therapies
Wuerzner G., Muller O., Burnier M., 2012. pp. 78-88 dans White H.D. (eds.) Advances in Acute Coronary Syndrome Management, Future Medicine.
[DOI][serval:BIB_E06B67E80062]
 
Blood pressure in hospitalized patients: should we still measure it?
Burnier M., 2012. Journal of Hypertension, 30 (10) pp. 1913-1914. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_33E57CFE1226]
Blood pressure target attainment in the background of guidelines: the very elderly in Swiss primary care.
Schäfer H.H., Sudano I., Theus G.R., Zilla P., Noll G., Burnier M., 2012. Family Practice, 29 (5) pp. 511-520.
[URN][DOI][WoS][Pmid][serval:BIB_610628896544]
 
Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension.
Guessous I., Dobrinas M., Kutalik Z., Pruijm M., Ehret G., Maillard M., Bergmann S., Beckmann J.S., Cusi D., Rizzi F. et al., 2012. Human Molecular Genetics, 21 (14) pp. 3283-3292. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1D2BE11940C7]
 
Différences induites par la définition des périodes diurnes et nocturnes sur la pression artérielle et le dipping lors d'une mesure ambulatoire de la pression artérielle [Effects of nighttime and daytime interval definition on blood pressure and dipping in patients referred for ambulatory blood pressure measurement].
Muller M.E., Bochud M., Pruijm M., Iglesias K., Burnier M., Wuerzner G., 2012. Annales de Cardiologie et d'Angéiologie, 61 (3) pp. 193-197. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F3AE32114BF1]
 
Dénervation rénale pour le traitement de l'hypertension artérielle résistante: proposition pour une attitude multidisciplinaire commune [Renal denervation in resistant hypertension: proposal for a common multidisciplinary attitude].
Muller O., Qanadli S.D., Waeber B., Wuerzner G., 2012. Revue Médicale Suisse, 8 (343) pp. 1159-1163.
[Pmid][serval:BIB_D30B1C161C7A]
Endothelin receptor antagonists: a place in the management of essential hypertension?
Burnier M., Forni V., 2012. Nephrology, Dialysis, Transplantation, 27 (3) pp. 865-868.
[URN][DOI][WoS][Pmid][serval:BIB_7A1B116930A5]
 
Genetic structure and admixture of the Seychelles' population.
Bady Pierre, Ehret Georg, Shamlaye Conrad, Burnier Michel, Mach Francois, Paccaud Fred, Delorenzi Mauro, Bovet Pascal, Bochud Murielle, 2012. pp. 170-170 dans 20th Annual Conference of the International Genetic Epidemiology Society (IGES 2011), Heidelberg, Germany, September 18-20, 2011, Genetic Epidemiology. Peer-reviewed.
[DOI][WoS][serval:BIB_7452118B9130]
Genome-wide association study to identify common variants associated with brachial circumference: a meta-analysis of 14 cohorts.
Boraska V., Day-Williams A., Franklin C.S., Elliott K.S., Panoutsopoulou K., Tachmazidou I., Albrecht E., Bandinelli S., Beilin L.J., Bochud M. et al., 2012. Plos One, 7 (3) pp. e31369 [10 p.]. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8B56012693D2]
 
Hypertension artérielle: une page se tourne!
Waeber B., Burnier M., Pechère Bertschi A., 2012. Revue Médicale Suisse, 8 (353) pp. 1691-1692.
[Pmid][serval:BIB_A6F0B091CC0F]
 
Impact of salt on cardiac differential gene expression and coronary lesion in normotensive mineralocorticoid-treated mice.
Wang Q., Domenighetti A.A., Schäfer S.C., Weber J., Simon A., Maillard M.P., Pedrazzini T., Chen J., Lehr H.A., Burnier M., 2012. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 302 (9) pp. R1025-R1033.
[DOI][Pmid][serval:BIB_5B4B77092495]
Incidence, complications and risk factors for severe falls in patients on maintenance haemodialysis.
Rossier A., Pruijm M., Hannane D., Burnier M., Teta D., 2012. Nephrology, Dialysis, Transplantation, 27 (1) pp. 352-357.
[URN][DOI][WoS][Pmid][serval:BIB_C2807B2CAE7C]
 
Management of hypertension in patients with diabetes mellitus and metabolic syndrome in Swiss primary care.
Schäfer H.H., de Villiers J.D., Sudano I., Theus G.R., Sivukhina E., Burnier M., Dieterle T., Noll G., 2012. International Journal of Clinical Practice, 66 (11) pp. 1125-1126.
[DOI][WoS][Pmid][serval:BIB_9A1A0F44ED45]
Mesure ambulatoire de la pression artérielle sur 24 heures
Gobin N., Wuerzner G., Waeber B., Burnier M., 2012. Forum Médical Suisse, 12 (31-32) pp. 600-607.
[URN][serval:BIB_4FF557BD795B]
 
Not all inflammatory markers are linked to kidney function: results from a population-based study.
Pruijm Menno, Ponte Belen, Vollenweider Peter, Mooser Vincent, Paccaud Fred, Waeber Gerard, Marques-Vidal Pedro, Burnier Michel, Bochud Murielle, 2012. American Journal of Nephrology, 35 (3) pp. 288-294. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_92E019EE2CF6]
 
Potassium restores vasorelaxation of resistance arterioles in non-hypertensive DOCA/salt fed mice.
Wyss C., Wang Q., Golshayan D., Nussberger J., Burnier M., Lehr H.A., Schaefer S.C., 2012. Microvascular Research, 84 (3) pp. 340-344.
[DOI][WoS][Pmid][serval:BIB_144C760DE345]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University